Journal of acquired immune deficiency syndromes (1999)
Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa.
Dessie Tien, Nomathemba Chandiwana, Gugulethu Shazi, Geoffrey Chen, Smart Mabweazara, Mahomed-Yunus S Moosa, Ravindra K Gupta, Deenan Pillay, Vincent C Marconi, Bethany Hedt-Gauthier, Willem D F Venter, Mark J Siedner, Suzanne M McCluskey, Jennifer Manne-Goehler
Published: 202510.1097/QAI.0000000000003812
Abstract
BACKGROUND: People with HIV (PWH) have experienced excess weight gain on tenofovir, lamivudine, and dolutegravir (TLD). The contribution of lifestyle behavior to this weight gain is poorly understood. METHODS: The Population Effectiveness of Dolutegr…
Preview only. Read the full abstract at the source